10^th Global Ophthalmology Meeting

Ocular immunology and inflammation

Ocular immunology and inflammation encompass a wide range of conditions affecting the eye's immune system, leading to inflammatory responses and tissue damage. This specialized conference track aims to convene ophthalmologists, immunologists, rheumatologists, researchers, and industry experts to explore the latest advancements, challenges, and innovations in the field.

Key Themes and Topics:

1. Immunological Basis of Ocular Inflammation: Explore the complex interplay between the innate and adaptive immune responses in ocular inflammation, including the role of cytokines, chemokines, and immune cells in the pathogenesis of uveitis, scleritis, and other inflammatory eye diseases.
2. Classification and Etiology of Uveitis: Review the various classification systems and etiological factors associated with uveitis, including infectious (e.g., viral, bacterial, parasitic), autoimmune (e.g., HLA-B27-associated uveitis, sarcoidosis), and idiopathic forms. Discuss the clinical features, diagnostic workup, and treatment options for different uveitic entities.
3. Scleritis and Keratitis: Discuss the pathophysiology, clinical manifestations, and management of scleritis and keratitis, inflammatory conditions affecting the sclera and cornea, respectively. Explore the role of immunosuppressive therapy, biologic agents, and surgical interventions in the treatment of severe or refractory cases.
4. Ocular Surface Inflammation: Examine the immunological mechanisms underlying ocular surface diseases, including dry eye syndrome, blepharitis, and meibomian gland dysfunction. Discuss the impact of inflammation on tear film stability, corneal epithelial integrity, and visual function.
5. Immunomodulatory Therapy: Evaluate the role of immunomodulatory agents, including corticosteroids, conventional immunosuppressants (e.g., methotrexate, azathioprine), biologic agents (e.g., TNF-alpha inhibitors, interleukin-6 inhibitors), and small molecule inhibitors (e.g., Janus kinase inhibitors), in the treatment of ocular inflammation.